- Filed
- May 28, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2026 · May 25, 2026 | 26.15M sh |
| Shares Diluted | FY 2026 · Mar 31, 2026 | 26.37M sh |
| Shares Diluted | FY 2026 · Mar 31, 2025 | 26.67M sh |
| Shares Diluted | FY 2026 · Mar 31, 2024 | 26.72M sh |
| Stock Repurchased | FY 2026 · Mar 31, 2026 | $30.63M |
| Stock Repurchased | FY 2026 · Mar 31, 2025 | $46.94M |
| Stock Repurchased | FY 2026 · Mar 31, 2024 | $9.85M |
| Dividends Paid | FY 2026 · Mar 31, 2026 | $19.66M |
| Dividends Paid | FY 2026 · Mar 31, 2025 | $0 |
| Dividends Paid | FY 2026 · Mar 31, 2024 | $0 |
| Capex | FY 2026 · Mar 31, 2026 | $4.43M |
| Capex | FY 2026 · Mar 31, 2025 | $5.27M |
| Capex | FY 2026 · Mar 31, 2024 | $7.66M |
| Operating Cash Flow | FY 2026 · Mar 31, 2026 | −$116.23M |
| Operating Cash Flow | FY 2026 · Mar 31, 2025 | $302.15M |
| Operating Cash Flow | FY 2026 · Mar 31, 2024 | $248.45M |
| Cash And Equivalents | FY 2026 · Mar 31, 2026 | $410.77M |
| Cash And Equivalents | FY 2026 · Mar 31, 2025 | $389.38M |
| Stockholders Equity | FY 2026 · Mar 31, 2026 | $1.07B |
| Stockholders Equity restated | FY 2026 · Mar 31, 2025 | $970.66M |
| Stockholders Equity restated | FY 2026 · Mar 31, 2024 | $897.44M |
| Stockholders Equity restated | FY 2026 · Mar 31, 2023 | $775.72M |
| Current Liabilities | FY 2026 · Mar 31, 2026 | $638.14M |
| Current Liabilities restated | FY 2026 · Mar 31, 2025 | $799.13M |
| Total Liabilities | FY 2026 · Mar 31, 2026 | $731.98M |
| Total Liabilities restated | FY 2026 · Mar 31, 2025 | $908.43M |
| Current Assets | FY 2026 · Mar 31, 2026 | $1.43B |
| Current Assets restated | FY 2026 · Mar 31, 2025 | $1.36B |
| Total Assets | FY 2026 · Mar 31, 2026 | $1.8B |
| Total Assets restated | FY 2026 · Mar 31, 2025 | $1.88B |
| Eps Diluted | FY 2026 · Mar 31, 2026 | $5.03 |
| Eps Diluted restated | FY 2026 · Mar 31, 2025 | $3.93 |
| Eps Diluted restated | FY 2026 · Mar 31, 2024 | $4.41 |
| Eps Basic | FY 2026 · Mar 31, 2026 | $5.05 |
| Eps Basic restated | FY 2026 · Mar 31, 2025 | $3.94 |
| Eps Basic restated | FY 2026 · Mar 31, 2024 | $4.44 |
| Sga Expense | FY 2026 · Mar 31, 2026 | $423.39M |
| Sga Expense restated | FY 2026 · Mar 31, 2025 | $386.68M |
| Sga Expense restated | FY 2026 · Mar 31, 2024 | $355.56M |
| Net Income | FY 2026 · Mar 31, 2026 | $132.64M |
| Net Income restated | FY 2026 · Mar 31, 2025 | $104.58M |
| Net Income restated | FY 2026 · Mar 31, 2024 | $117.98M |
| Operating Income | FY 2026 · Mar 31, 2026 | $166.15M |
| Operating Income restated | FY 2026 · Mar 31, 2025 | $99.69M |
| Operating Income restated | FY 2026 · Mar 31, 2024 | $133.81M |
| Gross Profit | FY 2026 · Mar 31, 2026 | $616.08M |
| Gross Profit restated | FY 2026 · Mar 31, 2025 | $512.12M |
| Gross Profit restated | FY 2026 · Mar 31, 2024 | $511.74M |